How Innovation is Catalyzing Growth in the China Benign Prostatic Hyperplasia Treatment Market
The China benign prostatic hyperplasia treatment market is on a robust growth trajectory, projected to reach a substantial market size of approximately 1,346.34 USD by 2035. This marks a significant increase from the current valuation of 708.06 USD, driven primarily by an annual growth rate of 5.5%. Such momentum indicates a strong demand for advanced treatment options as the population ages...
0 Комментарии 0 Поделились 16 Просмотры 0 предпросмотр